Quest Diagnostics Inc  

(Public, NYSE:DGX)   Watch this stock  
Find more results for DGX
Jul 11 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 50.46 - 64.10
Open     -
Vol / Avg. 0.00/1.79M
Mkt cap 8.58B
P/E 11.08
Div/yield 0.33/2.22
EPS 5.36
Shares 144.49M
Beta 0.67
Inst. own 107%
Jul 24, 2014
Q2 2014 Quest Diagnostics Earnings Release - 9:30AM EDT - Add to calendar
Jul 24, 2014
Q2 2014 Quest Diagnostics Inc Earnings Call - 8:30AM EDT - Add to calendar
Jun 10, 2014
Quest Diagnostics Inc at Goldman Sachs Healthcare Conference
May 21, 2014
Quest Diagnostics Annual Shareholder Meeting
May 8, 2014
Quest Diagnostics at Deutsche Bank Healthcare Conference - Webcast
Apr 24, 2014
Q1 2014 Quest Diagnostics Earnings Release
Apr 24, 2014
Q1 2014 Quest Diagnostics Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 6.36% 11.87%
Operating margin 11.91% 20.64%
EBITD margin - 19.59%
Return on average assets 4.81% 9.30%
Return on average equity 10.41% 20.00%
Employees 41,000 -
CDP Score - 59 D


3 Giralda Farms
United States - Map
+1-973-5202700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Quest Diagnostics Incorporated (Quest Diagnostics) is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. Quest Diagnostics offers United States patients and physicians the access to diagnostic testing services through its nationwide network of laboratories and Company-owned patient service centers. The Company provides interpretive consultation through the medical and scientific staff. The Company is a provider of clinical testing, including gene-based and esoteric testing and anatomic pathology services, and the provider of risk assessment services for the life insurance industry. The Company also is a provider of testing for clinical trials and testing for drugs of abuse. In April 2014, the Company announced the acquisition of Summit Health. Combined business will be referred to as Quest Diagnostics Health and Wellness Services.

Officers and directors

Stephen H. Rusckowski President, Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Mark J. Guinan Chief Financial Officer, Senior Vice President
Age: 52
Bio & Compensation  - Reuters
Lidia L. Fonseca Senior Vice President, Chief Information Officer
Age: 44
Bio & Compensation  - Reuters
Michael E. Prevoznik Senior Vice President, General Counsel
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jon Roger Cohen M.D. Senior Vice President, Chief Medical Officer
Age: 59
Bio & Compensation  - Reuters
Everett V. Cunningham Senior Vice President - Commercial
Age: 47
Bio & Compensation  - Reuters
James E. Davis Senior Vice President - Operations
Age: 51
Bio & Compensation  - Reuters
Catherine T. Doherty Senior Vice President - Clinical Franchises
Age: 51
Bio & Compensation  - Reuters
Daniel C. Stanzione Ph.D. Non-Executive Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
John C. Baldwin M.D. Independent Director
Age: 65
Bio & Compensation  - Reuters